Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REPLIGEN CORPORATION

(RGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société REPLIGEN CORPORATION
05/04REPLIGEN  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
05/04REPLIGEN  : Reported revenue was $142.8 million for the quarter, representing ye..
PU
05/04REPLIGEN CORP  : Results of Operations and Financial Condition, Financial Statem..
AQ
05/04REPLIGEN : Q1 Earnings Snapshot
AQ
05/04Repligen Reports First Quarter 2021 Financial Results and Updates Full Year 2..
GL
04/20Repligen to Report First Quarter 2021 Financial Results
GL
03/17Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor ..
GL
03/03Repligen Corporation to Present at Barclays Global Healthcare Conference
GL
02/24REPLIGEN  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
02/24REPLIGEN : 4Q Earnings Snapshot
AQ
02/24REPLIGEN CORP  : Results of Operations and Financial Condition, Financial Statem..
AQ
02/24Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
GL
02/22Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Confere..
GL
02/11Repligen to Report Fourth Quarter and Full Year 2020 Financial Results
GL
02/08Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the..
GL
01/28REPLIGEN CORP  : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year..
AQ
01/04Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Confere..
GL
2020Repligen Corporation Announces Closing of Public Offering of $312.2 Million, ..
GL
2020REPLIGEN CORP  : Entry into a Material Definitive Agreement, Other Events, Finan..
AQ
2020REPLIGEN  : EC Mergers & Acquisitions advised ARTeSYN on its Sale to Repligen
PR
2020Repligen Corporation Prices Public Offering of Shares of Common Stock
GL
2020Repligen Corporation Announces Proposed Public Offering of Shares of Common S..
GL
2020REPLIGEN  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020REPLIGEN : 3Q Earnings Snapshot
AQ
2020REPLIGEN CORP  : Results of Operations and Financial Condition, Financial Statem..
AQ
2020REPLIGEN  : Reports Third Quarter 2020 Financial Results and Updates Full Year 2..
AQ
2020Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2..
GL
2020REPLIGEN CORP  : Regulation FD Disclosure, Other Events, Financial Statements an..
AQ
2020REPLIGEN CORPORATION  : Announces Agreement to Acquire Bioprocess Systems Innova..
AQ
2020Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innova..
GL
2020REPLIGEN  : to Report Third Quarter 2020 Financial Results
AQ
2020Repligen to Report Third Quarter 2020 Financial Results
GL
2020REPLIGEN  : and Navigo Proteins Announce Achievement of Key Milestone in Develop..
AQ
2020REPLIGEN  : and Navigo Proteins Announce Achievement of Key Milestone in Develop..
AQ
2020Repligen and Navigo Proteins Announce Achievement of Key Milestone in Develop..
GL
2020REPLIGEN  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020REPLIGEN : 2Q Earnings Snapshot
AQ
2020REPLIGEN CORP  : Results of Operations and Financial Condition, Financial Statem..
AQ
2020Repligen Reports Second Quarter 2020 Financial Results and Updates Full Year ..
GL
2020Repligen to Report Second Quarter 2020 Financial Results
GL
2020REPLIGEN CORP  : Entry into a Material Definitive Agreement, Financial Statement..
AQ
2020REPLIGEN  : Current report filing
PU
2020REPLIGEN CORP  : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020Repligen Announces Agreement to Acquire Engineered Molding Technology
GL
2020REPLIGEN CORP  : Change in Directors or Principal Officers, Financial Statements..
AQ
2020Repligen Appoints Carrie Eglinton Manner to Board of Directors
GL
2020REPLIGEN CORP  : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2020REPLIGEN  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020REPLIGEN : 1Q Earnings Snapshot
AQ
2020REPLIGEN CORP  : Results of Operations and Financial Condition, Financial Statem..
AQ
2020Repligen Reports First Quarter 2020 Financial Results and Updates Full Year 2..
GL
2020Repligen to Report First Quarter 2020 Financial Results
GL
2020REPLIGEN CORP  : Change in Directors or Principal Officers, Financial Statements..
AQ
2020Repligen Appoints Rohin Mhatre, Ph.D. to Board of Directors
GL
2020REPLIGEN  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020REPLIGEN CORP  : Results of Operations and Financial Condition, Financial Statem..
AQ
2020REPLIGEN : 4Q Earnings Snapshot
AQ
2020Repligen Reports Fourth Quarter and Full Year 2019 Financial Results
GL
2020Repligen to Report Fourth Quarter and Full Year 2019 Financial Results
GL
2020Repligen to Present at the 38th Annual J.P. Morgan Healthcare Conference
GL
2019Repligen Reports Third Quarter 2019 Financial Results and Updates Full Year 2..
GL
2019Repligen Reports Second Quarter 2019 Financial Results and Updates Full Year ..
GL
2019Repligen to Report Second Quarter 2019 Financial Results
GL
2019Repligen Corporation Announces Closing of Public Offerings of $138.1 Million ..
GL
2019Repligen Corporation Announces Pricing of Public Offerings of $120 million of..
GL
2019Repligen Corporation Announces Proposed Public Offerings of $100 million of C..
GL
2019Repligen to Present at Jefferies 2019 Healthcare Conference
GL
2019Repligen to Report First Quarter 2019 Financial Results
GL
2019Repligen Corporation Announces Proposed Public Offering of Shares of Common S..
GL
2019Repligen Corporation Announces Agreement to Acquire Process Analytics Innovat..
GL
2019Repligen Reports Fourth Quarter and Full Year 2018 Financial Results
GL
2019Repligen to Report Fourth Quarter and Full Year 2018 Financial Results
GL
2018Repligen to Report Third Quarter 2018 Financial Results
GL
2018Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-G..
GL
2018Repligen Reports Second Quarter 2018 Financial Results
GL
1  2  3  4Next
Upcoming event on REPLIGEN CORPORATION